Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Hepatic Diseases and Disorders News

FDA alert
FDA Alert
Elafibranor Receives Accelerated FDA Approval for PBC
06/14/2024
The first-in-class PPAR is the first new medicine approved in nearly a decade for primary biliary cholangitis.
The first-in-class PPAR is the first new medicine approved in nearly a decade for primary biliary cholangitis.
The first-in-class PPAR is the...
06/14/2024
Gastroenterology
News
Prophylactic Antibiotics Investigated for Severe ALD
09/11/2023

Rebecca Mashaw, Managing Editor

Rebecca Mashaw, Managing Editor ...
A clinical trial sought to determine if a combination of antibiotics and corticosteroids improved mortality among patients with alcohol-related hepatitis.
A clinical trial sought to determine if a combination of antibiotics and corticosteroids improved mortality among patients with alcohol-related hepatitis.
A clinical trial sought to...
09/11/2023
Gastroenterology
News
Sugary Beverages May Yield Bitter Results in HCC
08/28/2023
Do sugar-sweetened drinks raise the risk of liver cancer? Researchers report from the Women’s Health Initiative.
Do sugar-sweetened drinks raise the risk of liver cancer? Researchers report from the Women’s Health Initiative.
Do sugar-sweetened drinks raise...
08/28/2023
Gastroenterology

Advertisement

FDA Alert
News
FDA Grants Fast Track Designation for Efinopegdutide for NASH
06/21/2023

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
Merck will present phase 2a findings on its investigational glucagon-like peptide 1/glucagon receptor coagonist at the European Association for the Study of the Liver conference on June 23.
Merck will present phase 2a findings on its investigational glucagon-like peptide 1/glucagon receptor coagonist at the European Association for the Study of the Liver conference on June 23.
Merck will present phase 2a...
06/21/2023
Gastroenterology
Liver drawing
News
OCA Plus Bezafibrate Gets FDA Orphan Drug Approval for PBC
06/06/2023
But the agency’s Gastrointestinal Drugs Advisory Committee voted against accelerated approval for obeticholic acid for treatment of nonalcoholic steatohepatitis with precirrhotic liver fibrosis, saying the benefits do not outweigh the risks.
But the agency’s Gastrointestinal Drugs Advisory Committee voted against accelerated approval for obeticholic acid for treatment of nonalcoholic steatohepatitis with precirrhotic liver fibrosis, saying the benefits do not outweigh the risks.
But the agency’s...
06/06/2023
Gastroenterology
News
Access to Gastroenterology Care Associated With Liver Disease Mortality
06/06/2023
Up to 40% of mortality from alcohol-associated liver disease may be attributable to differences in the geographic density of gastroenterologists.
Up to 40% of mortality from alcohol-associated liver disease may be attributable to differences in the geographic density of gastroenterologists.
Up to 40% of mortality from...
06/06/2023
Gastroenterology

Advertisement

News
Cases of Primary Sclerosing Cholangitis Rising Across North America
01/01/2023
A systematic review shows incidence and prevalence of primary sclerosing cholangitis is low in the Mediterranean region while it rises in Northern Europe, as well.
A systematic review shows incidence and prevalence of primary sclerosing cholangitis is low in the Mediterranean region while it rises in Northern Europe, as well.
A systematic review shows...
01/01/2023
Gastroenterology
News
Downstaging Therapy Can Enable HCC Resection
12/09/2022
Unresectable hepatocellular carcinoma can be successfully downstaged through systemic therapy and other modalities, greatly improving overall survival, new research shows.
Unresectable hepatocellular carcinoma can be successfully downstaged through systemic therapy and other modalities, greatly improving overall survival, new research shows.
Unresectable hepatocellular...
12/09/2022
Gastroenterology
News
‘Disturbing Finding’: Pandemic Delayed Care for Patients with Chronic Liver Disease
08/30/2022
A new survey found that more than 10% of patients reported a negative impact on their liver diseases post-COIVD, and majority of them were because of delays in follow-up care.
A new survey found that more than 10% of patients reported a negative impact on their liver diseases post-COIVD, and majority of them were because of delays in follow-up care.
A new survey found that more...
08/30/2022
Gastroenterology

Advertisement

News
New Study Quantifies Link Between NAFLD and Heart Failure
08/16/2022
Researchers found that nonalcoholic fatty liver disease may be associated with a 1.5-fold higher long-term risk of new-onset heart failure.
Researchers found that nonalcoholic fatty liver disease may be associated with a 1.5-fold higher long-term risk of new-onset heart failure.
Researchers found that...
08/16/2022
Gastroenterology

Advertisement

Advertisement

Advertisement

Advertisement

Sign up for our e-Newsletters

Gastroenterology Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

News

News
Novel AI System Shows Success in Detection of Adenomas
08/27/2024
CAD-EYE detection system significantly improved the number of adenomas detected per colonoscopy without extending the procedure time, according to a recent report.
CAD-EYE detection system significantly improved the number of adenomas detected per colonoscopy without extending the procedure time, according to a recent report.
CAD-EYE detection system...
08/27/2024
Gastroenterology
News
Implementation of Fecal Immunochemical Test-Based Program in Colorectal Cancer Screening
08/20/2024
Investigators studied whether fecal immunochemical test programs might be feasible options for improving colorectal cancer screening in areas with limited resources.
Investigators studied whether fecal immunochemical test programs might be feasible options for improving colorectal cancer screening in areas with limited resources.
Investigators studied whether...
08/20/2024
Gastroenterology
News
Low-Dose Aspirin and Prevention of Colorectal Cancer
08/14/2024
Results of a new study showed that low-dose aspirin use is associated with a lower risk of colorectal cancer.
Results of a new study showed that low-dose aspirin use is associated with a lower risk of colorectal cancer.
Results of a new study showed...
08/14/2024
Gastroenterology
News
FIT Screening Associated With Lower Risk of Death From CRC
08/06/2024
Findings of a new study support the role of fecal immunochemical testing in reducing mortality from colorectal cancer, researchers report.
Findings of a new study support the role of fecal immunochemical testing in reducing mortality from colorectal cancer, researchers report.
Findings of a new study support...
08/06/2024
Gastroenterology
FDA
News
FDA Approves First Blood Test for Primary CRC Screening
07/30/2024
Shield is the first blood test cleared for primary colorectal cancer screening that meets Medicare performance requirements.
Shield is the first blood test cleared for primary colorectal cancer screening that meets Medicare performance requirements.
Shield is the first blood test...
07/30/2024
Gastroenterology
News
Colorectal Cancer Risk Higher Among Patients WIth PSC, With or Without IBD
07/24/2024
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and...
07/24/2024
Gastroenterology
News
Ultraprocessed Food Linked to Elevated Risk of CRC
07/24/2024
C olorectal cancer, colon cancer, and noncardia gastric cancer were found to be associated with high consumption of ultraprocessed foods, according to recent research.
C olorectal cancer, colon cancer, and noncardia gastric cancer were found to be associated with high consumption of ultraprocessed foods, according to recent research.
C olorectal cancer, colon...
07/24/2024
Gastroenterology
FDA alert
News
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test
06/28/2024
The device can provide results in an hour from a fingertip blood test.
The device can provide results in an hour from a fingertip blood test.
The device can provide results...
06/28/2024
Gastroenterology
FDA alert
FDA Alert
Elafibranor Receives Accelerated FDA Approval for PBC
06/14/2024
The first-in-class PPAR is the first new medicine approved in nearly a decade for primary biliary cholangitis.
The first-in-class PPAR is the first new medicine approved in nearly a decade for primary biliary cholangitis.
The first-in-class PPAR is the...
06/14/2024
Gastroenterology
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
05/24/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
05/24/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use